• breastfeeding mother and child

    Breast milk can be powerful, but can it stop the new coronavirus?

    There is a lot we do not know about SARS-CoV-2, the virus that causes COVID-19, including how it may interact with human milk. However, researchers at the University of Texas Medical Branch are trying to figure out if breast milk has any innate ability to stop the spread of the virus that causes COVID-19, or if an infected mother can pass antibodies to her breastfeeding child.

  • Covid virus image

    UTMB researchers find Pfizer vaccine effective against new COVID-19 strain

    A collaborative team from The University of Texas Medical Branch at Galveston and Pfizer has shown that the common mutation N501Y from the newly emerged SRAS-CoV-2 strains does not compromise Pfizer’s COVID-19 vaccine. This is the first study to investigate if the fast-spreading new virus strains affects the vaccine’s effectiveness. The study is currently available in bioRxiv (https://doi.org/10.1101/2021.01.07.425740).

  • Helping the helpers: New program will provide counseling to domestic violence and sexual assault program workers

    In times of calamity and uncertainty, we are often told to look for the helpers. But what happens when no one is looking out for them? Domestic violence and sexual assault has increased during the COVID-19 pandemic and, with it, the demands on those who provide services and support to survivors. But while the demands are up for domestic violence and sexual assault workforce, the resources and support for these essential workers has not increased.

  • New Study Links Increased Risk of Cancer to Proximity to Oil Refineries

    A team of physicians, environmental scientists, and students at the University of Texas Medical Branch have completed a multi-year study of cancer rates among individuals living in close proximity to oil refineries and have found statistically significant increases in several cancers among those living nearest to these facilities.

  • UTMB to terminate Aetna contract

    The University of Texas Medical Branch is terminating its commercial contract with Aetna because the insurance company does not pay UTMB at a competitive rate. UTMB has sent a letter of termination to Aetna that calls for termination of the contract effective May 6, 2021.

  • UTMB study shows spike mutation in COVID-19

    A multidisciplinary team from The University of Texas Medical Branch at Galveston has shown a dominant mutation D614G of the SARS-CoV-2 spike protein enhances viral replication in the upper respiratory airway, which may contribute to the increased transmission of COVID-19. This finding is important in understanding the evolution of SARS-CoV-2 as well as in the development of vaccines and therapeutic antibodies. The study is currently available in Nature.